ORTHO
BULLETS
Free CME
Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 6279

Bisphosphonates QID: 6279 (SAE08PA.18)
In scope icon L 1 E
QID 6279 (Type "6279" in App Search)
It has been shown that bisphosphonate-based supportive therapy (pamidronate or zoledronate) reduces skeletal events (onset or progression of osteolytic lesions) both in patients with multiple myeloma and in cancer patients with bone metastasis. The use of biphosphonate therapy has been associated with
Type in at least one full word to see suggestions list